Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Neuro-Oncology Practice
|
August 15, 2025
Imaging progression after radiotherapy for IDH mutant low-grade glioma: Sometimes it is best to stay calm and stay the course
Solmaz Sahebjam, Lawrence Kleinberg
Neuro-Oncology Practice
|
January 15, 2024
Towards gender equity in neuro-oncology
Solmaz Sahebjam, Heather Leeper
Genes & Development
|
October 7, 2022
Modeling YAP fusions: a paradigm for investigating rare cancers?
Solmaz Sahebjam, Mark R Gilbert
Arthritis and Rheumatism
|
March 1, 2007
Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice
Solmaz Sahebjam, Rama Khokha, John S Mort
Clinical Advances in Hematology & Oncology : H&O
|
August 17, 2012
Management of glioblastoma in the elderly
Solmaz Sahebjam, Mairead McNamara, Warren P Mason
CNS Oncology
|
July 24, 2014
Emerging biomarkers in anaplastic oligodendroglioma: implications for clinical investigation and patient management
Solmaz Sahebjam, Mairéad G McNamara, Warren P Mason
Cancers
|
November 9, 2013
Emerging biomarkers in glioblastoma
Mairéad G McNamara, Solmaz Sahebjam, Warren P Mason
Current Treatment Options in Neurology
|
January 25, 2013
Anaplastic oligodendroglioma: advances and treatment options
Mairéad G McNamara, Solmaz Sahebjam, Warren P Mason
The Oncologist
|
August 2, 2012
The utility of hedgehog signaling pathway inhibition for cancer
Solmaz Sahebjam, Lillian L Siu, Albiruni A Razak
Journal of Neuro-Oncology
|
June 2, 2017
Immunotherapy and radiation in glioblastoma
Solmaz Sahebjam, Andrew Sharabi, Michael Lim, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Neuro-Oncology Practice
|
August 15, 2025
Imaging progression after radiotherapy for IDH mutant low-grade glioma: Sometimes it is best to stay calm and stay the course
Solmaz Sahebjam, Lawrence Kleinberg
Neuro-Oncology Practice
|
January 15, 2024
Towards gender equity in neuro-oncology
Solmaz Sahebjam, Heather Leeper
Genes & Development
|
October 7, 2022
Modeling YAP fusions: a paradigm for investigating rare cancers?
Solmaz Sahebjam, Mark R Gilbert
Arthritis and Rheumatism
|
March 1, 2007
Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice
Solmaz Sahebjam, Rama Khokha, John S Mort
Clinical Advances in Hematology & Oncology : H&O
|
August 17, 2012
Management of glioblastoma in the elderly
Solmaz Sahebjam, Mairead McNamara, Warren P Mason
CNS Oncology
|
July 24, 2014
Emerging biomarkers in anaplastic oligodendroglioma: implications for clinical investigation and patient management
Solmaz Sahebjam, Mairéad G McNamara, Warren P Mason
Cancers
|
November 9, 2013
Emerging biomarkers in glioblastoma
Mairéad G McNamara, Solmaz Sahebjam, Warren P Mason
Current Treatment Options in Neurology
|
January 25, 2013
Anaplastic oligodendroglioma: advances and treatment options
Mairéad G McNamara, Solmaz Sahebjam, Warren P Mason
The Oncologist
|
August 2, 2012
The utility of hedgehog signaling pathway inhibition for cancer
Solmaz Sahebjam, Lillian L Siu, Albiruni A Razak
Journal of Neuro-Oncology
|
June 2, 2017
Immunotherapy and radiation in glioblastoma
Solmaz Sahebjam, Andrew Sharabi, Michael Lim, et al.
Page
of 9